1,157 Shares in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Purchased by Quest Partners LLC

Quest Partners LLC acquired a new position in Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The firm acquired 1,157 shares of the pharmacy operator’s stock, valued at approximately $30,000.

A number of other large investors also recently modified their holdings of the company. New York Life Investment Management LLC grew its stake in shares of Walgreens Boots Alliance by 0.4% in the third quarter. New York Life Investment Management LLC now owns 114,506 shares of the pharmacy operator’s stock valued at $2,547,000 after buying an additional 499 shares in the last quarter. Fulton Bank N.A. grew its stake in shares of Walgreens Boots Alliance by 0.5% in the fourth quarter. Fulton Bank N.A. now owns 107,071 shares of the pharmacy operator’s stock valued at $2,796,000 after buying an additional 523 shares in the last quarter. Insight Folios Inc grew its stake in shares of Walgreens Boots Alliance by 5.8% in the fourth quarter. Insight Folios Inc now owns 9,640 shares of the pharmacy operator’s stock valued at $252,000 after buying an additional 525 shares in the last quarter. Pinnacle Financial Partners Inc grew its stake in shares of Walgreens Boots Alliance by 4.9% in the fourth quarter. Pinnacle Financial Partners Inc now owns 11,866 shares of the pharmacy operator’s stock valued at $310,000 after buying an additional 555 shares in the last quarter. Finally, Westpac Banking Corp grew its stake in shares of Walgreens Boots Alliance by 10.1% in the fourth quarter. Westpac Banking Corp now owns 6,100 shares of the pharmacy operator’s stock valued at $159,000 after buying an additional 560 shares in the last quarter. 58.59% of the stock is currently owned by hedge funds and other institutional investors.

Walgreens Boots Alliance Trading Up 5.4 %

NASDAQ:WBA opened at $16.22 on Friday. The company has a quick ratio of 0.32, a current ratio of 0.66 and a debt-to-equity ratio of 0.50. The business’s 50 day moving average is $17.95 and its two-hundred day moving average is $20.97. Walgreens Boots Alliance, Inc. has a 52 week low of $14.62 and a 52 week high of $32.89.

Walgreens Boots Alliance (NASDAQ:WBAGet Free Report) last announced its quarterly earnings results on Thursday, March 28th. The pharmacy operator reported $1.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.82 by $0.38. The business had revenue of $37.05 billion for the quarter, compared to the consensus estimate of $35.86 billion. Walgreens Boots Alliance had a positive return on equity of 12.11% and a negative net margin of 4.18%. The business’s revenue was up 6.3% on a year-over-year basis. During the same quarter last year, the business posted $1.16 EPS. On average, research analysts predict that Walgreens Boots Alliance, Inc. will post 3.22 earnings per share for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, June 12th. Investors of record on Tuesday, May 21st will be issued a $0.25 dividend. This represents a $1.00 annualized dividend and a dividend yield of 6.17%. The ex-dividend date of this dividend is Monday, May 20th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is -14.29%.

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on WBA. Leerink Partnrs reiterated a “market perform” rating on shares of Walgreens Boots Alliance in a research note on Monday, February 26th. Truist Financial restated a “hold” rating and set a $25.00 price objective on shares of Walgreens Boots Alliance in a research note on Monday, April 1st. TD Cowen lowered their price objective on Walgreens Boots Alliance from $37.00 to $35.00 and set a “buy” rating for the company in a research note on Wednesday, April 3rd. UBS Group lowered their price objective on Walgreens Boots Alliance from $25.00 to $22.00 and set a “neutral” rating for the company in a research note on Wednesday, April 3rd. Finally, Morgan Stanley lowered their price objective on Walgreens Boots Alliance from $16.00 to $13.00 and set an “underweight” rating for the company in a research note on Friday. Four analysts have rated the stock with a sell rating, ten have issued a hold rating and two have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $23.86.

Get Our Latest Analysis on Walgreens Boots Alliance

Insider Buying and Selling

In related news, Director Inderpal S. Bhandari purchased 3,000 shares of the business’s stock in a transaction that occurred on Thursday, April 11th. The shares were acquired at an average price of $18.05 per share, with a total value of $54,150.00. Following the acquisition, the director now owns 3,000 shares in the company, valued at approximately $54,150. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. In other Walgreens Boots Alliance news, Director Inderpal S. Bhandari bought 3,000 shares of the business’s stock in a transaction on Thursday, April 11th. The shares were purchased at an average price of $18.05 per share, with a total value of $54,150.00. Following the purchase, the director now directly owns 3,000 shares of the company’s stock, valued at $54,150. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Manmohan Mahajan bought 6,000 shares of the business’s stock in a transaction on Tuesday, April 2nd. The shares were acquired at an average cost of $19.38 per share, for a total transaction of $116,280.00. Following the purchase, the chief financial officer now directly owns 166,969 shares in the company, valued at $3,235,859.22. The disclosure for this purchase can be found here. Company insiders own 17.40% of the company’s stock.

About Walgreens Boots Alliance

(Free Report)

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.

Featured Stories

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBAFree Report).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.